McKesson EBITDA 2012-2026 | MCK
McKesson annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- McKesson EBITDA for the quarter ending June 30, 2026 was $1.514B, a 26.91% increase year-over-year.
- McKesson EBITDA for the twelve months ending June 30, 2026 was $7.262B, a 43.72% increase year-over-year.
- McKesson 2026 annual EBITDA was $6.941B, a 37.23% increase from 2025.
- McKesson 2025 annual EBITDA was $5.058B, a 11.31% increase from 2024.
- McKesson 2024 annual EBITDA was $4.544B, a 8.92% decline from 2023.
|
McKesson Annual EBITDA (Millions of US $) |
|
|---|---|
| 2026 | $6,941 |
| 2025 | $5,058 |
| 2024 | $4,544 |
| 2023 | $4,989 |
| 2022 | $2,798 |
| 2021 | $-3,911 |
| 2020 | $3,550 |
| 2019 | $3,914 |
| 2018 | $3,930 |
| 2017 | $8,322 |
| 2016 | $4,438 |
| 2015 | $4,226 |
| 2014 | $3,174 |
| 2013 | $2,928 |
| 2012 | $2,617 |
|
McKesson Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-06-30 | $1,514 |
| 2026-03-31 | $2,346 |
| 2025-12-31 | $1,807 |
| 2025-09-30 | $1,595 |
| 2025-06-30 | $1,193 |
| 2025-03-31 | $1,742 |
| 2024-12-31 | $1,377 |
| 2024-09-30 | $741 |
| 2024-06-30 | $1,198 |
| 2024-03-31 | $1,376 |
| 2023-12-31 | $801 |
| 2023-09-30 | $1,108 |
| 2023-06-30 | $1,259 |
| 2023-03-31 | $1,141 |
| 2022-12-31 | $1,389 |
| 2022-09-30 | $1,275 |
| 2022-06-30 | $1,184 |
| 2022-03-31 | $795 |
| 2021-12-31 | $483 |
| 2021-09-30 | $734 |
| 2021-06-30 | $786 |
| 2021-03-31 | $1,237 |
| 2020-12-31 | $-7,003 |
| 2020-09-30 | $960 |
| 2020-06-30 | $895 |
| 2020-03-31 | $1,126 |
| 2019-12-31 | $689 |
| 2019-09-30 | $867 |
| 2019-06-30 | $868 |
| 2019-03-31 | $1,074 |
| 2018-12-31 | $982 |
| 2018-09-30 | $930 |
| 2018-06-30 | $928 |
| 2018-03-31 | $988 |
| 2017-12-31 | $1,068 |
| 2017-09-30 | $1,014 |
| 2017-06-30 | $860 |
| 2017-03-31 | $4,986 |
| 2016-12-31 | $1,035 |
| 2016-09-30 | $1,087 |
| 2016-06-30 | $1,214 |
| 2016-03-31 | $962 |
| 2015-12-31 | $1,140 |
| 2015-09-30 | $1,176 |
| 2015-06-30 | $1,160 |
| 2015-03-31 | $1,172 |
| 2014-12-31 | $1,048 |
| 2014-09-30 | $1,045 |
| 2014-06-30 | $961 |
| 2014-03-31 | $845 |
| 2013-12-31 | $656 |
| 2013-09-30 | $856 |
| 2013-06-30 | $817 |
| 2013-03-31 | $865 |
| 2012-12-31 | $629 |
| 2012-09-30 | $733 |
| 2012-06-30 | $701 |
| 2012-03-31 | $767 |
| 2011-12-31 | $629 |
| 2011-09-30 | $614 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $104.880B | $403.430B |
| McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |